Back
LENZ Therapeutics Stock Price Chart

Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
88
LENZ
LENZ Therapeutics
Last Price:
$31.30
Seasonality Move:
30.41%
7 Day Trial
ALL ACCESS PASS
$
7

Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LENZ is experiencing slight buying pressure.
LENZ Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.73 | Buy |
20-day SMA: | 28.77 | Buy |
50-day SMA: | 26.39 | Buy |
200-day SMA: | 26.59 | Buy |
8-day EMA: | 29.94 | Buy |
20-day EMA: | 28.87 | Buy |
50-day EMA: | 27.35 | Buy |
200-day EMA: | 25.7 | Buy |
LENZ Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.07 | Buy |
Relative Strength Index (14 RSI): | 66.34 | Buy |
Chaikin Money Flow: | 448046 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LENZ Therapeutics Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for LENZ Therapeutics Stock
Is LENZ Therapeutics Stock a Buy?
-
LENZ Therapeutics share price is 31.96 while LENZ 8-day simple moving average is 29.73, which is a Buy signal.
-
The stock price of LENZ is 31.96 while LENZ Therapeutics 20-day SMA is 28.77, which makes it a Buy.
-
LENZ Therapeutics 50-day simple moving average is 26.39 while LENZ share price is 31.96, making it a Buy technically.
-
LENZ stock price is 31.96 and LENZ Therapeutics 200-day simple moving average is 26.59, creating a Buy signal.
LENZ Technical Analysis vs Fundamental Analysis
Buy
88
LENZ Therapeutics (LENZ)
is a Buy
Is LENZ Therapeutics a Buy or a Sell?
-
LENZ Therapeutics stock is rated a BuyThe current LENZ Therapeutics [LENZ] share price is $31.96. The Score for LENZ is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
LENZ Therapeutics Stock Info
Market Cap:
899.6M
Price in USD:
31.96
Share Volume:
476.6K
LENZ Therapeutics 52-Week Range
52-Week High:
38.93
52-Week Low:
14.92
Buy
88
LENZ Therapeutics (LENZ)
is a Buy
LENZ Therapeutics Share Price Forecast
-
What is the LENZ Therapeutics stock price today?The LENZ Therapeutics stock price is 31.96 USD today.
-
Will LENZ stock go up or go down?LENZ Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is LENZ Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, LENZ Therapeutics is not overvalued.
Is LENZ Therapeutics Stock a Buy?
-
LENZ Therapeutics share price is 31.96 while LENZ 8-day exponential moving average is 29.94, which is a Buy signal.
-
The stock price of LENZ is 31.96 while LENZ Therapeutics 20-day EMA is 28.87, which makes it a Buy.
-
LENZ Therapeutics 50-day exponential moving average is 27.35 while LENZ share price is 31.96, making it a Buy technically.
-
LENZ stock price is 31.96 and LENZ Therapeutics 200-day simple moving average is 25.70, creating a Buy signal.
Fundamental Analysis of LENZ Therapeutics
Is LENZ Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.72 per share, and a decrease next year of $0.23 per share.
Technical Analysis of LENZ Therapeutics
Should I short LENZ Therapeutics stock?
-
LENZ Moving Average Covergence Divergence (MACD) indicator is 1.07, suggesting LENZ Therapeutics is a Buy
-
LENZ Therapeutics Relative Strength Index (RSI) is 66.34, which suggest LENZ Therapeutics is overbought
-
The Bollinger Bands (25) for LENZ Therapeutics is ( - ), which suggest LENZ Therapeutics is a Buy
-
The Bollinger Bands (100) for LENZ Therapeutics is ( - ), which suggest LENZ Therapeutics is a Buy
* LENZ Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.